Valdepharm is an API manufacturer based in France. It holds 6 active US drug master files across a filed portfolio of 10 molecules. Its GMP standing is certified by ANSM (FR), EMA and MFDS (Korea). Its most recent recorded inspection, by US FDA, closed on 21 January 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Cedex, United Arab Emirates | Not on file |
| VAL DE REUIL, France | Not on file |
| VAL-DE-REUIL, France | Not on file |
| Val De Reuil Cedex, France | Not on file |
| France, France | 3000538143 |
| Molecule | Regulators | Docs |
|---|---|---|
| Estradiol | SFDA (Saudi Arabia), US FDA | 3 |
| Norethisterone | US FDA | 2 |
| Estradiol Valerate | US FDA | 1 |
| Relebactam | SFDA (Saudi Arabia) | 1 |
| Trazodone | US FDA | 1 |
| エストラジオール吉草酸エステル | PMDA (Japan) | 1 |
| エストラジオール水和物 | PMDA (Japan) | 1 |
| トラゾドン塩酸塩 | PMDA (Japan) | 1 |
| 無菌アリピプラゾール水和物 | PMDA (Japan) | 1 |
| 酢酸ノルエチンドロン | PMDA (Japan) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 1 | None |
| ANSM (FR) | None | 48 |
| EMA | None | 2 |
| MFDS (Korea) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $115.8M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Valdepharm comes back tiered against every other supplier able to file there.
Start for free